In
terms of revenue, the global single-use bioprocessing
market was valued at USD 32.52 billion in 2024 and is predicted to increase
from 37.81 billion in 2025 to USD 146.84 billion by 2034.
The single-use bioprocessing market is driven by cost reduction, increased production, simplified disposal, sustainable manufacturing processes, efficient use of time and resources, and the minimization of cross-contamination.
Browse the Detail Insights@ https://www.precedenceresearch.com/single-use-bioprocessing-market
Single-use bioprocessing is a method of producing biopharmaceuticals using disposable systems that are thrown away after use. It is a popular choice for pharmaceutical creator because it is a cost-effective, efficient, and reduces the risk of contamination.
The Full Study is Readily Available | Download the Sample Pages of this Report@ https://www.precedenceresearch.com/sample/1308
Single-use Bioprocessing Market Highlights:
🔹 North America dominated the global market with the largest market share of 35% in 2024.
🔹 Asia Pacific is expected to grow at the fastest CAGR during the forecast period 2025 to 2034.
🔹 The simple and peripheral elements segment contributed the highest market share in 2024.
🔹 The upstream bioprocessing segment generated the highest market share in 2024.
🔹 The biopharmaceutical manufacturers segment dominated the market in 2024.
Set up a meeting at your convenience to get more insights instantly! https://www.precedenceresearch.com/schedule-meeting
Market Overview and Industry Potential
The single-use bioprocessing refers to using single-use systems and technology in biopharmaceutical production. The biopharmaceutical products including proteins, enzymes, medications, vaccines, liquid formulations, etc. must be bioprocessed and produced with high sterility, quality, and effectiveness. The commonly used single-use systems are polyethylene (PE) and polypropylene (PP), polyethersulfone (PES), cellulose acetate (CA), polyamide (PA), and polycarbonate.
These components exhibit ideal properties as they are transparent, heat resistant, chemically inert to aqueous media, durable, and mechanically resistant. All of these are approved by the U.S. FDA and are widely applicable in food and pharmaceutical industries.
The leading manufacturers of single-use components are Merck-Millipore, Thermo Fisher Scientific Inc., Sartorius, etc. Several industrial processes like monoclonal antibody purification, enzyme assays, nucleic acid purification, etc. require the use of single-use systems during production cycles to avoid cross-contamination and extra maintenance.
AI-Driven Advancements in Single-Use Bioprocessing Technologies
The integration of artificial intelligence into industrial bioprocessing workflows helps to enhance predictive analytics, quality control, process optimization, etc. This ensures excellent scalability and product consistency in response to emerging and developing markets. Some of biopharma companies are making efforts to enhance biopharma research with AI-powered cell simulations.
AI utilizes predictive analytics and machine learning to enhance the control and automation of bioreactors which ensures the consistent maintenance of optimal environmental conditions. AI helps to streamline the production processes and facilitate the scalability and sustainability of operations. Pfizer utilizes AI and machine learning to monitor mammalian cell culture bioreactors in real time through the Manufacturing Intelligence Edge (MI Edge) platform created using AWS.
Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/1308
Major Trends in the Single-Use Bioprocessing Market
Increased usage of single-use products in Biopharmaceutical Manufacturing:
These products include tubings for disposable applications, disposable filter cartridges, empty bags, buffer containers, bioreactors, depth filters, connectors, clamps, etc. About 46% decline in total water and energy consumption, 35% more favorable CO2 footprint, and 40% lower initial investment costs are observed through the implementation of single-use bioprocessing technologies. This usage offers cost reduction due to time savings, less demand for instrumentation, lower investment costs, and water and energy savings. They provide agility, scalability, and flexibility in biopharmaceutical production.
Automated Bulk Filling Systems for Monitored Single-Use Processes:
The automated bulk filling systems for single-use bags are cost-saving and time-efficient solutions for both bulk and laboratory purposes. They are ideal for managing the entire pharmaceutical logistics process including filling, freezing, thawing, filtration, etc. Single-use bioprocess containers or single-use bags are compact and require less storage space than bulky cryovessels or bottles. The ease of availability in different sizes and capacities, and compatibility with bioprocess containers of any size and brand drive the adoption of single-use technologies and systems.
Single-use Bioprocessing Market Report Coverage:
|
Report Coverage |
Details |
|
Market Size in 2024 |
USD 32.52 Billion |
|
Market Size in 2025 |
USD 37.81 Billion |
|
Market Size by 2034 |
USD 146.84 Billion |
|
CAGR 2025-2034 |
16.27% |
|
Dominating Region |
North America |
|
Base Year |
2024 |
|
Forecast Period |
2025 to 2034 |
|
Historic Period |
2020 to 2023 |
|
Segments Covered |
Product, End User, Application, Workflow, and Region |
|
Regions Covered |
North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
For
questions or customization requests, please reach out to us @ sales@precedenceresearch.com | +1 804 441 9344 The Key Players Shaping the Future of the Single-Use Bioprocessing Market The
single-use bioprocessing market is witnessing unprecedented growth as
pharmaceutical and biotech companies increasingly embrace disposable
technologies for efficiency, flexibility, and cost reduction. As the demand for
biologics, vaccines, and personalized medicine
continues to rise, industry leaders are stepping up their game, driving
innovation, and redefining manufacturing processes. 🔹 Thermo Fisher Scientific, Inc. 🔹 Sartorius AG 🔹 Merck KGaA 🔹 Pall Corporation 🔹 Corning Incorporated 🔹 Eppendorf AG 🔹 General Electric Company (GE
Healthcare) 🔹 Lonza 🔹 Rentschler Biopharma SE 🔹 JM BioConnect 🔹 Meissner Filtration Products, Inc. 🔹 Infors AG 🔹 BoehringerIngelheim GmbH 🔹 Entegris, Inc. 🔹 PBS Biotech, Inc. Key Regional Analysis: U.S. Single-use Bioprocessing Market Size 2025 to 2034 The
U.S. single-use bioprocessing market size is calculated at USD 9.26 billion in
2025 and is expected to be worth around USD 36.75 billion by 2034. The market
is expected to grow at a compound annual growth rate (CAGR) of 16.51% from 2025
to 2034. North
America dominated the single-use bioprocessing market in 2024 due to the huge
growth and development of biopharmaceutical industries in this region. The
outbreak of epidemic and pandemic cases surges the need for heavy government
investments in research and development of vaccines, diagnostics testing, and drugs. Over US$
480 million was sanctioned by the U.S. government to Moderna Inc. to
develop COVID-19 vaccines. The
presence of large-scale production units, the huge adoption of disposables, the
heavy expenditure in healthcare, and the well-established healthcare
infrastructure contribute majorly to the market’s growth in this region. The
presence of several contract manufacturers dedicated to investments and
large-scale production also expands the market. The Bio-process System
Alliance (BPSA) in North America aims to advance the adoption of single-use
systems and technologies in this region. The increased focus on vaccine
production for disease prevention and taking actionable measures accelerates
the success of this market. 🔹 In September 2024, Millipore
Sigma announced the launch of a single-use reactor for the manufacturing of
antibody-drug conjugates by reporting the 70% efficiency of single-use reactors
than traditional methods. Asia
Pacific is expected to be the fastest-growing region in the single-use
bioprocessing market during the forecast period due to the developments in
nations such as China, India, and Japan. The increasing investments by
biotechnology and pharmaceutical companies also surge the demand and need
for these systems. The expansion of contract manufacturers leads to the
regional success as the manufacturing hub for pharmaceuticals. The efforts of
contract service providers to develop and expand their businesses in the Asia
Pacific region propel the market’s growth. The implementation of disposables in
CMOs drives continuous investments by global as well as local companies. The
enhancement of CDMO capacities supports the growing manufacturing needs in this
region. China is leading with the expansion of the biopharmaceutical
market. The various international companies expanded their manufacturing units
by establishing partnerships with China-based entities that are mutually
beneficial. The increased focus of this region to develop affordable
biosimilars. 🔹 In July 2024, Nirrin
Technologies announced the launch of its Atlas system for precise analysis
of critical data which helps to transform bioprocess analysis and deliver
product titer quantitation in downstream processing applications. Single-Use Bioprocessing Market Segments Analysis: Product Analysis The
media bags and containers segment dominated the single-use bioprocessing market
in 2024 due to the increasing use of media bags and container and their
benefits such as low investments, lower waste emission, and lower operational
costs in biopharmaceutical industries. The ideal properties of these materials
such as temperature resistance, durability, etc. drive this segmental growth. The
extensive use of media bags and containers in biopharmaceutical industries
surges this segmental growth in the market. Bioprocessing bags, single-use
bioprocessing containers, and cell culture media storage containers, are some
of the types of media bags and containers that offer flexibility,
biocompatibility, chemical compatibility, and customization features. The wide applications
of these products for handling liquids in bioprocessing, research, production,
storage, and maintenance of quality and sterility of cell culture media, etc.
uplift this segmental growth. End User Analysis The
biopharmaceutical manufacturers segment dominated the single-use bioprocessing
market in 2024 due to the expansion of 80% of biopharmaceutical plants and the
adoption of single-use bioprocessing systems as cheaper, more efficient, and
more reliable solutions. The extensive use of single-use disposables by
contract manufacturers augmented this segmental growth. Moreover, the rising
demand for single-use bioprocessing systems in several bioprocessing services
drives the market’s growth and the segmental growth globally. The
commercial increase in
biologics and the rise in contract manufacturing services and research
services upsurge the segmental growth. The beneficial offerings by CROs and
CMOs in bioprocessing operations such as scalability, flexibility, reduced
internal infrastructure needs, and dedicated supply channels augment the
segmental growth. The huge adoption of contract services is impacting
industrial growth globally. The
academic and clinical research institutes segment is expected to be the
fastest-growing in the single-use bioprocessing market during the forecast
period due to the availability of benchtop scale bioprocessing appliances and
technological advancements in single-use systems. The National Institute for
Bioprocessing Research provides contract research services for biologics
through the conduct of workshops and training for single-use technologies. The
contribution of academic institutes and scientific communities in developing
new biologics such as cell and gene therapies and vector production causes an
increase in the implementation of single-use systems due to their cost
reduction and flexibility benefits. Application Analysis The
filtration segment dominated the single-use bioprocessing market in 2024 due to
the rising adoption of single-use bioprocessing systems and related
technologies in filtration. These solutions are efficient for performing
filtration on small and large scales. They are ideal for reducing bioburden,
ultrafiltration, and polishing of biomolecules. It contributes to reducing
waste, pollution, and demand for natural resources. It requires less
maintenance and reduces errors in production processes which drives the growth
of the filtration segment significantly. Workflow Analysis The
upstream segment dominated the single-use bioprocessing market in 2024 due to
the increased utilization of single-use bioprocessing technologies in the early
stages of bioprocessing. The wide adoption of these technological solutions in
the cultivation and preparation of cells or microorganisms for further
biomanufacturing drives this segmental growth. The use of disposable
bioreactors, mixers, containers, connectors, tubing, probes, sensors, and
sampling systems in upstream processing boosts the segmental growth in the
market. The
excellent advantages including reduced timelines, low operational costs, and
fewer cleaning needs also drive the upstream segment significantly. Moreover,
the developments and advancements in upstream
bioprocessing technologies surge their demand and need in
industries. The advanced products like bioreactor systems offer high-throughput
upstream process developments. They also offer efficient cell culture
processing and media and feed optimization with the help of automated experimental
setup and sampling which drives their expansion in industrial workflows. The
fermentation segment is expected to be the fastest-growing in the single-use
bioprocessing market over the forecast period due to its benefits in the
optimization of microbial fermentation, flexibility, ease of use, and
efficiency. The fewer sample requirements and reduced validation needs also
drive the segmental growth remarkably. The benefits like rapid scaling of
fermentation processes accelerate the adoption of single-use fermentation
bioprocessing. The
launch of several innovative fermenters providing optimum conditions for
bioprocessing reactions accelerates their expansion in the market. Many
companies are focusing on delivering single-use fermentation solutions to their
potential customers which include a stirred tank system with powerful mixing,
high oxygen transfer capacities for microbial cell culture, efficient temperature
control, etc. Browse More Research Reports: 🔹 Downstream Processing
Market: https://www.precedenceresearch.com/downstream-processing-market 🔹 Bioprocess Containers
Market: https://www.precedenceresearch.com/bioprocess-containers-market 🔹 Small-scale Bioreactors
Market: https://www.precedenceresearch.com/small-scale-bioreactors-market 🔹 Biotechnology Contract
Manufacturing Market: https://www.precedenceresearch.com/biotechnology-contract-manufacturing-market 🔹 Bioreactors Market: https://www.precedenceresearch.com/bioreactors-market 🔹 Single-use Bioreactors
Market: https://www.precedenceresearch.com/single-use-bioreactors-market 🔹 Bioprocess Technology
Market: https://www.precedenceresearch.com/bioprocess-technology-market Biotechnology Contract Manufacturing Market: Competitive Landscape and Major Breakthroughs in the Single-Use
Bioprocessing Market The
single-use bioprocessing market continues to evolve rapidly and showcases
significant advancements through innovations in 2023 and 2024, with a dynamic
competitive landscape. Major players such as Sartorius AG, Thermo Fisher
Scientific Inc., Eppendorf AG, Lonza, General Electric Company, etc. hold a
prominent position in the single-use bioprocessing market. These companies
exhibit promising resources and technical expertise to conduct R&D,
production, manufacturing, marketing, upstream and downstream processing, etc.
in diverse research areas and provide promising products and services through
successful industrial results. The companies also contribute to the increased
revenue share in the market through strategic collaborations, trustful
investments, and outsourcing. What is Going Around the Globe? 🔹In July 2024, Thermo Fisher
Scientific Inc. announced the launch of biobased films for its single-use
technology bioprocessing containers (BPCs) which have obtained the
International Sustainability and Carbon Certification (ISCC). 🔹In August 2023, Sartorius
and Repligen Corporation announced the launch of an integrated
bioreactor system with the incorporation of Repligen’s XCell Alternating
Tangential Flow (ATF) upstream intensification technology into the Sartorius
Biostat Stirred-Tank Reactor (STR) bioreactor. The research report categorizes the Single-use Bioprocessing Market into
the following segments and subsegments: By Product 🔹 Filtration Assemblies 🔹 Disposable Bioreactors 🔹 Disposable Mixers 🔹 Media Bags & Containers 🔹 Others By Application 🔹 Filtration 🔹 Purification 🔹 Cell Culture 🔹 Others By End User 🔹 Biopharmaceutical Manufacturers 🔹 Clinical & Academic Research
Institutes 🔹 Others By Workflow 🔹 Upstream 🔹 Fermentation 🔹 Downstream By Geography 🔹 North America 🔹 Europe 🔹 Asia Pacific 🔹 Latin America 🔹 Middle East & Africa (MEA) Thanks
for reading you can also get individual chapter-wise sections or region-wise
report versions such as North America, Europe, or Asia Pacific. Immediate
Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/1308 You can place an order or ask any
questions, please feel free to contact at sales@precedenceresearch.com | +1 804 441 9344 Precedence
Research offers exclusive subscription services designed to provide in-depth
data and analytics insights. With a subscription, you gain access to a comprehensive
suite of statistical resources, market intelligence, and research tools
tailored to your business needs. Whether you're looking for industry trends,
competitive analysis, or future market projections, our subscription plans
ensure you stay ahead with reliable, up-to-date information. Browse
Our Subscription Plans@ https://www.precedenceresearch.com/get-a-subscription About
Us Precedence
Research is a worldwide market research and consulting organization. We give an
unmatched nature of offering to our customers present all around the globe
across industry verticals. Precedence Research has expertise in giving
deep-dive market insight along with market intelligence to our customers spread
crosswise over various undertakings. We are obliged to serve our different
client base present over the enterprises of medicinal services, healthcare,
innovation, next-gen technologies, semi-conductors, chemicals, automotive, and
aerospace & defense, among different ventures present globally. Web:
https://www.precedenceresearch.com Our
Blogs: Towards Healthcare | Towards Packaging |Statifacts |Towards EV Solutions | Towards Dental | Towards Automotive |Nova One Advisor For
Latest Update Follow Us: 
